The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 40, Issue 2, 2007, Pages 145-150

  Bogunia Kubik, K ^a   Jaskula, E ^a   Lange, A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; DNA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DELETION MUTANT; DONOR; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; RISK FACTOR; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECURRENCE; SEQUENCE DELETION; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447286195     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705703     Document Type: Article

References (20)

1. Lusso P. HIV and the chemokine system: 10 years later. EMBO J 2006; 25: 447-456.
2. Wald O, Pappo O, Ari ZB, Azzaria E, Wiess ID, Gafnovitch I et al. The CCR5Δ32 allele is associated with reduced liver inflammation in hepatitis C virus infection. Eur J Immunogenet 2004; 31: 249-252.
3. Venkatesan S, Petrovic A, Van Ryk DI, Locati M, Weissman D, Murphy PM. Reduced cell surface expression of CCR5 in CCR5Δ32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem 2002; 277: 2287-2301.
4. Uchihara JN, Krensky AM, Matsuda T, Kawakami H, Okudaira T, Masuda M et al. Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. Int J Cancer 2005; 114: 747-755.
5. Zaunders JJ, Kaufmann GR, Cunningham PH, Smith D, Grey P, Suzuki K et al. Increased turnover of CCR5 + and redistribution of CCR5-CD4T lymphocytes during primary human immunodeficiency virus type 1 infection. J Infect Dis 2001; 183: 736-743.
6. Trautmann A. Chemokines as immunotransmitters? Nat Immunol 2005; 6: 427-428.
7. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
8. Smith KM, Crandall KA, Kneissl ML, Navia BA. PCR detection of host and HIV-1 sequences from archival brain tissue. J Neurovirol 2000; 6: 164-171.
9. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615-3620.
10. Hoshino Y, Kimura H, Tanaka N, Tsuge I, Kudo, K, Horibe K et al. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogeneic stem cell transplantation. Br J Haenwtol 2001; 115: 105-111.
11. Bogunia-Kubik K, Mlynarczewska A, Jaskula E, Lange A. The presence of IFN-γ 3/3 genotype in the recipient associates with increased risk for EBV reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2006; 132: 326-332.
12. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. The dispersal of mucosal memory B cells: Evidence from persistent EBV infection. Immunity 2002; 16: 745-754.
13. Vassiliadou N, Tucker L, Anderson DJ. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J Immunol 1999; 162: 7510-7518.
14. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: E45.
15. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30 e36.
16. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus an Epstein-Barr virus infections. HERPES 2003; 10: 60-65.
17. Murai M, Yoneyama H, Ezaki T, Suematsu M, Terashima Y, Harada A et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154-160.
18. Bogunia-Kubik K, Duda D, Suchnicki K, Lange A. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91: 1628-1634.
19. Molon B, Gri G, Bettella M, Gomez-Mounton C, Lanzavecchia A, Martinez C et al. T cell costimulation by chemokine receptors. Nat Immunol 2005; 6: 465-471.
20. Holler E. Cytokines, viruses, and graft-versus-host disease. Curr Opin Hematol 2002; 9: 479-484.